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The Gram-positive obligate anaerobe Clostridium difficile causes potentially fatal intestinal diseases. How this organism regu-
lates virulence gene expression is poorly understood. In many bacterial species, the second messenger cyclic di-GMP (c-di-GMP)
negatively regulates flagellar motility and, in some cases, virulence. c-di-GMP was previously shown to repress motility of C. dif-
ficile. Recent evidence indicates that flagellar gene expression is tightly linked with expression of the genes encoding the two C.
difficile toxins TcdA and TcdB, which are key virulence factors for this pathogen. Here, the effect of c-di-GMP on expression of
the toxin genes tcdA and tcdB was determined, and the mechanism connecting flagellar and toxin gene expressions was exam-
ined. In C. difficile, increasing c-di-GMP levels reduced the expression levels of tcdA and tcdB, as well as that of tcdR, which en-
codes an alternative sigma factor that activates tcdA and tcdB expression. We hypothesized that the C. difficile orthologue of the
flagellar alternative sigma factor SigD (FliA; 28) mediates regulation of toxin gene expression in response to c-di-GMP. Indeed,
ectopic expression of sigD in C. difficile resulted in increased expression levels of tcdR, tcdA, and tcdB. Furthermore, sigD expres-
sion enhanced toxin production and increased the cytopathic effect of C. difficile on cultured fibroblasts. Finally, evidence is
provided that SigD directly activates tcdR expression and that SigD cannot activate tcdA or tcdB expression independent of
TcdR. Taken together, these data suggest that SigD positively regulates toxin genes in C. difficile and that c-di-GMP can inhibit
both motility and toxin production via SigD, making this signaling molecule a key virulence gene regulator in C. difficile.
Clostridium difficile, a Gram-positive obligate anaerobe, is aleading cause of nosocomial infections in North America, Eu-
rope, and Australia (1–5). C. difficile infections (CDIs) are ex-
tremely costly to treat and represent a substantial economic bur-
den (6–8). The bacterium is transmitted between hosts as a
dormant spore, a metabolically inactive form that is resistant to
oxygen and to many common disinfectants. CDI often occurs
following antibiotic use, which disrupts the intestinal microbiota
and allows C. difficile spores to germinate in and colonize the
intestine. In the large intestine, C. difficile produces cytotoxins that
cause a range of disease manifestations, including diarrhea and
potentially lethal pseudomembranous colitis.
Two Rho GTPase-glucosylating cytotoxins, TcdA and TcdB,
are key virulence factors of C. difficile, and both have been shown
to play important roles in disease by using animal models (9, 10).
Several regulators of expression of the tcdA and tcdB genes have
been identified to date. Two regulators, TcdR and TcdC, are en-
coded in the pathogenicity locus that also encodes TcdA and
TcdB. TcdR is an alternative sigma factor that positively regulates
transcription of tcdA and tcdB (11, 12). TcdC may function as an
anti-sigma factor that impedes the activity of TcdR, although
some reports have found that TcdC does not affect toxin produc-
tion (13–17). In addition, the global transcriptional regulator
CodY represses tcdA, tcdB, and tcdR expression during exponen-
tial growth in response to GTP and branched-chain amino acids
and acts primarily by controlling expression of tcdR (18, 19). The
catabolite control protein CcpA represses toxin gene expression
(but not tcdR expression) in response to glucose (20, 21). SigH, an
alternative sigma factor involved in controlling gene expression
during entry into stationary phase, also affects toxin gene expres-
sion (22), although the regulatory mechanisms involved have not
been determined. Finally, Spo0A, a regulator of sporulation initi-
ation, has been implicated in the regulation of toxin gene expres-
sion, but these findings remain controversial (23–25).
Flagella have been shown to play a significant role in the colo-
nization of host tissues by a wide variety of bacteria (26–30). Fla-
gella and motility have been implicated in the ability of C. difficile
to cause disease in animal models, but there are conflicting data on
the exact way in which flagella impact virulence. One study sug-
gested a positive influence of flagella on intestinal colonization
using animal models but relied on comparisons of nonisogenic
isolates (31). Studies of isogenic C. difficile mutants with inser-
tions in the flagellar filament genes fliC and fliD, which encode
flagellin and flagellar cap proteins, respectively, suggested that fla-
gella and/or motility is detrimental for attachment to host cells in
vitro and for virulence in hamsters (32, 33). However, the fliC and
fliD mutants produced more TcdA and TcdB toxins (33), so the
specific contribution of FliC and FliD to virulence is unclear. A
recent study showed that mutations in other flagellar genes (fliF,
fliG, fliM, flhB, and sigD), each of which caused a loss of motility,
resulted in significantly decreased toxin gene expression; a subset
of these nonmotile mutants was tested in the hamster model of
CDI, and some but not all of the mutants were attenuated for
virulence (34). Although the exact regulatory relationship be-
tween flagellar and toxin gene expressions is unknown, it is clear
that mutation of flagellar genes impacts the ability of C. difficile to
cause disease, whether by a direct effect on flagellum-mediated
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colonization, an indirect effect on toxin production, or a combi-
nation of the two.
Recently, we reported that the bacterial second messenger cy-
clic diguanylate (c-di-GMP) inhibits swimming motility of C. dif-
ficile (35). The c-di-GMP signaling molecule negatively regulates
the flagellar motility of a large number of bacteria by diverse
mechanisms, including transcriptional, posttranscriptional, and
posttranslational control (36–44). In C. difficile, regulation of mo-
tility by c-di-GMP likely occurs through a direct effect of c-di-
GMP on the expression of a putative large flagellar operon, the
flgB operon, via a c-di-GMP riboswitch (45). This riboswitch,
named Cd1, was shown previously to respond to c-di-GMP levels
in a heterologous host (Bacillus subtilis), and in vitro analysis of
Cd1 RNA indicates that Cd1 interacts directly with c-di-GMP to
trigger premature transcription termination (45). A recent study
that focused on identifying regulatory RNAs in C. difficile experi-
mentally confirmed the expression of Cd1 riboswitch RNA corre-
sponding to the 160-nucleotide terminated transcript and dem-
onstrated that elevated c-di-GMP levels increase the abundance of
the terminated Cd1 riboswitch RNA in vivo (46). These findings
support a direct effect of c-di-GMP on the transcription of the flgB
operon, providing a mechanism by which c-di-GMP represses
motility of C. difficile.
The putative flgB operon contains genes predicted to encode
proteins involved in the early steps of flagellar biosynthesis, such
as flagellar hook, basal body, MS ring, motor, and other assembly
proteins. Among the genes in the flgB operon is sigD, which is
predicted to encode an alternative sigma factor. The orthologues
of SigD present in many Gram-negative bacteria (in which ortho-
logues are typically named FliA or 28) and Gram-positive bacte-
ria positively regulate the expression of flagellar genes in a hierar-
chical manner that allows the bacteria to link flagellar gene
expression to the assembly of the flagellum (47–55). Best charac-
terized in Gram-negative bacteria, and in Salmonella enterica se-
rovar Typhimurium in particular, hierarchical control of flagellar
gene expression by FliA is accomplished through control of fliA
transcription and through posttranslational control of FliA by the
anti-sigma factor FlgM (56–62). Specifically, FliA activity is antag-
onized by FlgM until the hook-basal body structure is assembled,
and FlgM is secreted from the cell through the assembled complex
(48, 63–65). The FlgM concentration in the cell decreases, allow-
ing FliA, in conjunction with RNA polymerase, to activate its tar-
get promoters, typically those controlling the expression of “late-
stage” flagellar components such as flagellin, flagellar motor
proteins, and chemotaxis proteins. In the model Gram-positive
bacterium B. subtilis, SigD similarly positively regulates genes in-
volved in flagellum synthesis, motility, and chemotaxis in a hier-
archical fashion involving antagonism of SigD activity by FlgM
(66–72). The genetic organization of the flagellar locus of C. diffi-
cile differs from those of both Gram-negative bacteria and B. sub-
tilis, and much remains to be experimentally demonstrated regarding
the operon arrangements, regulatory relationships between flagellar
genes, and functionality of orthologues of known flagellar gene reg-
ulators.
Previously, we showed that C. difficile with elevated intracellu-
lar levels of c-di-GMP has reduced expression levels of flgB and
sigD (35). Elevated c-di-GMP levels also resulted in reduced ex-
pression levels of flgM, which lies upstream of the flgB operon and
is thus expected to be indirectly impacted by c-di-GMP. We pre-
dicted that SigD mediates the effect of high c-di-GMP levels on the
expression of late-stage flagellar genes. Because c-di-GMP regu-
lates the expression of flagellar genes, and flagellar gene mutations
impact the expression of toxin genes, we hypothesize that c-di-
GMP also regulates the expression of the toxin genes. Indeed, C.
difficile with a mutation in sigD (annotated fliA and named ac-
cordingly by Aubry et al.) was previously shown to be nonmotile
and to express lower levels of tcdR, tcdA, and tcdB (34). In this
study, we investigated the effect of altering intracellular c-di-GMP
levels on toxin production by C. difficile and assessed the role of
SigD in regulating toxin gene expression in response to c-di-GMP.
Our results provide evidence that c-di-GMP is a key regulator of
virulence genes in C. difficile and that the alternative sigma factor
SigD plays a central role in this regulation.
MATERIALS AND METHODS
Bacterial strains and growth conditions. Table S1 in the supplemental
material lists the bacterial strains and plasmids used in this study. C. dif-
ficile strains were grown at 37°C under anaerobic conditions in BHIS or
TY medium as specified previously (35, 73). Escherichia coli and Bacillus
subtilis were grown in LB broth at 37°C with aeration (74). When appro-
priate, the following antibiotics were used at the indicated concentrations:
ampicillin (Amp) at 100 g/ml, chloramphenicol (Cm) at 10 g/ml, thi-
amphenicol (Tm) at 10 g/ml, kanamycin (Km) at 100 g/ml, and eryth-
romycin (Erm) at 5 g/ml. Nisin was used for induction of gene expres-
sion at a final concentration of 1 g/ml unless otherwise indicated.
DNA manipulations and strain construction. Table S2 in the supple-
mental material lists the oligonucleotides used in this study. C. difficile 630
genomic DNA was used as the template for all PCRs unless otherwise
specified. All DNA modification enzymes were purchased from New Eng-
land BioLabs.
For expression of sigD in C. difficile, sigD (CD0266) was amplified by
PCR using primers sigDCdeF and sigDCdeR, which introduced BamHI
and PstI restriction sites, respectively. The digested fragment was cloned
into similarly digested pMC-Pcpr (35). Clones were confirmed by PCR
with primers pUCmcsF and m13r, resulting in plasmid pSigD. Plasmid
pSigD was introduced into E. coli HB101(pRK24) cells by electroporation.
The HB101(pRK24) donor strain was then mated with C. difficile strains
630 and JIR8094, resulting in the transfer of pSigD into C. difficile.
Transconjugants were selected on BHIS medium with 10 g/ml thiam-
phenicol (BHIS-Tm) supplemented with kanamycin to prevent growth of
the E. coli donor strain. Isolates were confirmed by PCR with primers
pUCmcsF and m13r (to confirm the presence of the plasmid) and with
primers tcdBqF and tcdBqR (to confirm C. difficile), resulting in strains
RT731 and RT747.
To generate a C. difficile tcdR mutant, the Targetron method was used
(75, 76) but with a modified set of template and delivery plasmids (77).
The Targetron was targeted to a sequence within tcdR, AAAAAAGCG
ATG. The targeted intron fragment was generated by PCR, amplifying one
portion from pBL64 using primers EBSuniv and tcdRibs1 and the other
portion from pBL65 using primers tcdRebs1 and tcdRebs2. The PCR
products were combined and used as the template in a second round of
PCR with primers tcdRibs1 and tcdRebs1, which allowed splicing of the
two initial PCR products into a single targeted intron fragment. The in-
tron fragment was digested with BsrGI and HindIII and cloned into
pBL100. The resulting plasmid, pBL100::tcdR::ermB, was confirmed by
PCR and sequencing and then introduced into E. coli HB101(pRK24).
Plasmid pBL100::tcdR::ermB was transferred into erythromycin-sensitive
C. difficile 630Erm by conjugation. Transconjugants were selected on
BHIS-Tm-Km medium. Isolates with Targetron insertions were selected
by screening transconjugants for resistance to erythromycin and then
confirmed to have an insertion in tcdR by PCR with primers tcdRqF and
tcdRrev. These primers yielded a 323-bp product from C. difficile with a
wild-type tcdR allele and a 2.3-kb product from the C. difficile 630Erm
tcdR::ermB mutant (see Fig. S5A in the supplemental material). The C.
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difficile tcdR::ermB mutant was further confirmed by Western blotting for
TcdA, the production of which is positively regulated by TcdR (see Fig.
S5B in the supplemental material) (11, 12). Plasmids pMC-Pcpr and
pSigD were introduced into the tcdR::ermB mutant by conjugation, as
described above.
The B. subtilis lacZ reporter strains were made in multiple steps. First,
genomic DNA from a B. subtilis strain containing a plasmid insertion
(pLC5, which confers Cm resistance) in sigD (50) was transformed into
MC202 (78). Cm-resistant colonies were screened for the incorporation
of plasmid pLC5 into sigD by PCR, and strain RT838 was obtained. The
following promoters of interest were amplified by PCR from C. difficile
630 chromosomal DNA (using the primers indicated in parentheses):
PtcdA (PtcdAFB and PtcdARH), PtcdB (PtcdBFB and PtcdBRH), PtcdR
(PtcdRFB and PtcdRRH), and PflgM (PflgMFB and PflgMRH). The pro-
moter fragments were cloned into pHK23, upstream of the promoterless
lacZ gene, using BamHI and HindIII sites introduced by using the prim-
ers. Correct clones were confirmed by PCR, and the corresponding plas-
mids were named pRT822 to pRT825. The Pcpr::sigD fusion was amplified
from pSigD by using primers PcprF-XbaI and sigDR-XbaI and then
cloned into the XbaI site in plasmids pRT822 to pRT825. PCR was used to
identify plasmids with the Pcpr::sigD insert in the orientation opposite that
of the promoter-lacZ fusion (i.e., with divergent transcription). The re-
sulting plasmids with both the promoter-lacZ and Pcpr::sigD fusions,
pRT828 to pRT831, were transformed into B. subtilis strain RT838, lead-
ing to recombination of both fusions into the amyE locus. The resulting B.
subtilis reporter strains were confirmed by testing for a loss of spectino-
mycin resistance and by PCR to detect both fusions.
RNA isolation and quantitative real-time PCR. Measurements of
transcript abundance using quantitative reverse transcriptase PCR (qRT-
PCR) were used as an indication of expression levels, as described previ-
ously (35). RNA was isolated from exponential-phase (optical density
[OD] at 600 nm of 0.6 to 0.8) or early-stationary-phase (OD at 600 nm
of 1.0 to 1.2, approximately 16 h) cultures grown in BHIS medium, as
indicated. When strains were grown in TY medium, RNA was isolated
from early-stationary-phase cultures (OD at 600 nm of 2.0 to 2.2). RNA
samples were treated with DNase I, cDNA was synthesized, and qRT-
PCRs were done as described previously (35). The rpoC gene was used as
the reference in all experiments (79). Primers were designed by using the
PrimerQuest tool from IDT DNA Technologies and follow the naming
pattern gene-qF and gene-qR for the forward and reverse primers, respec-
tively (see Table S2 in the supplemental material). Control reaction mix-
tures lacking reverse transcriptase were included for all templates and all
primer sets. At least 3 biological replicates were assayed. The data were
analyzed by using the CT method and are expressed as the fold change
in the transcript level under the test condition compared to the average for
the indicated control and then normalized to the reference gene rpoC.
Statistical analyses were done by using GraphPad Prism 5 software.
Western blots. C. difficile strains with the indicated expression plas-
mids were grown in BHIS-Tm medium, with or without 1 g/ml nisin, to
exponential phase (OD at 600 nm of 0.6 to 0.8) or early stationary phase
(OD at 600 nm of 1.0 to 1.2), as indicated for each experiment. Cells
were collected by centrifugation from 1 ml of cultures with equivalent
optical densities, and the supernatants were filter sterilized. Proteins from
cell pellets were suspended directly in Laemmli sample buffer (80). Pro-
teins in the supernatants (from cultures normalized to the OD at 600 nm)
were trichloroacetic acid (TCA) precipitated prior to resuspending the
proteins in sample buffer. Samples were separated on 4 to 15% SDS-
polyacrylamide gels (Bio-Rad). After transfer onto nitrocellulose, the
membranes were probed with mouse anti-TcdA or anti-TcdB antibodies
(Novus Biologicals) or rabbit anti-CodY antibodies (gift from A. L.
Sonenshein) (19). The membranes were then probed with IR800 goat
anti-mouse or anti-rabbit secondary antibodies, as appropriate (Thermo-
Fisher). Imaging was done by using an Odyssey Imager (Li-Cor Biologi-
cals). At least 3 biological replicates for each strain were analyzed, and a
representative image is shown.
Analysis of cytopathic effects on target cells. C. difficile strains with
the indicated expression plasmids were grown in BHIS-Tm medium with
1 g/ml nisin to exponential phase (OD at 600 nm of 0.6 to 0.8) and
early stationary phase (OD at 600 nm of 1.0 to 1.2). Cells were removed
by centrifugation, and the supernatants were filter sterilized. Twofold se-
rial dilutions of the supernatants were applied onto semiconfluent cul-
tures of primary human foreskin fibroblasts grown in Dulbecco’s modi-
fied Eagle’s medium (DMEM) supplemented with 10% newborn calf
serum in 96-well plates. After 21 h, the cytopathic effect (CPE) was as-
sessed visually to determine the toxin titer. The toxin titer was defined as
the highest dilution for which complete (100%) rounding was observed
for the fibroblast cells (9). Four biological replicates were tested, and each
biological replicate was assayed in triplicate. The data were analyzed by the
Mann-Whitney test. For each biological replicate of the stationary-phase
samples, at least one representative well was photographed at a 40 mag-
nification.
Reporter assays. B. subtilis reporter strains were grown overnight at
37°C in LB broth with the appropriate antibiotic selection; diluted 1:50
into the same medium supplemented with 0, 0.5, 1 or 2 g/ml nisin; and
then grown for 6 h at 37°C with aeration. -Galactosidase activity in B.
subtilis lysates was measured by using previously described methods and is
reported as Miller units (74, 81). Assays were each performed by using 3
biological replicates and were performed independently at least twice.
Data were analyzed by using unpaired t tests comparing induced to unin-
duced cultures.
RESULTS
Expression of tcdA and tcdB is repressed in C. difficile with ele-
vated c-di-GMP levels. We previously reported a method for
manipulating intracellular c-di-GMP levels in C. difficile (35).
This method involves the expression of dccA, which encodes a
diguanylate cyclase (DGC), under the control of the nisin-induc-
ible promoter Pcpr. Expression of dccA in C. difficile was shown to
result in 2- to 2,000-fold-increased c-di-GMP levels, depending
on the concentration of nisin used to induce dccA expression. The
intracellular c-di-GMP concentration was unaffected in C. difficile
expressing dccAmut, an allele encoding a catalytically inactive DGC
(35). Using this system, c-di-GMP was shown to repress the mo-
tility of C. difficile, at least in part by decreasing the expression
levels of specific flagellar genes (35). Among the genes with re-
duced transcript levels in C. difficile with elevated c-di-GMP levels
were flgB, flgM, and sigD, which represent at least two distinct
flagellar operons. The flagellar locus consists of a putative 22-kb
operon beginning with flgB (CD0245) and likely at least two ad-
ditional operons immediately upstream of the flgB operon (see
Fig. S1 in the supplemental material). The upstream operon(s)
contains “late-stage” flagellar genes, including, among others, the
flagellin gene fliC and a glycosyltransferase (CD0240) involved in
posttranslational modification of flagellin (82). To further exam-
ine the extent to which c-di-GMP regulates the expression of genes
in the flagellar locus, the fliC, fliI, motA, CD0240, and CD0241
transcripts, which are located throughout the flagellar locus, were
chosen to broadly represent the entire locus, and their levels were
measured by qRT-PCR. The levels of these transcripts were re-
duced by over 90% in C. difficile with elevated c-di-GMP levels
(see Fig. S2 in the supplemental material), indicating that c-di-
GMP controls C. difficile motility by directly or indirectly repress-
ing the expression of several flagellar genes representing multiple
operons.
Because c-di-GMP represses flagellar gene expression (35), and
flagellar gene mutations were previously shown to affect the ex-
pression of genes in the C. difficile pathogenicity locus (33, 34), we
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predicted that c-di-GMP would also regulate toxin gene expres-
sion. We used the nisin-inducible DGC system described above to
artificially increase c-di-GMP levels in C. difficile and then exam-
ined toxin gene expression and toxin production. First, qRT-PCR
was used to measure tcdA and tcdB transcript levels in C. difficile
630 with pDccA, pDccAmut, or the vector (pMC-Pcpr) grown in
BHIS-Tm medium with or without 1 g/ml of the inducer nisin.
Both tcdA and tcdB transcript levels were significantly reduced in
C. difficile overexpressing dccA, but not in the dccAmut or vector
controls, upon induction with nisin (Fig. 1A); the tcdA and tcdB
transcript levels were reduced to 5% and 11%, respectively, of the
transcript levels in the induced vector controls. The level of the
codY transcript, previously shown not to be regulated by c-di-
GMP, was not affected by dccA expression (see Fig. S2 in the sup-
plemental material) (35). The level of c-di-GMP in C. difficile with
pDccA grown with 1 g/ml nisin is anticipated to be very high
compared to basal levels; this concentration of nisin was previ-
ously determined to result in 1,000-fold-increased intracellular
c-di-GMP levels (35). Therefore, the effect of more subtle in-
creases in c-di-GMP levels on toxin gene expression was assessed.
To do this, the level of the tcdA transcript in C. difficile with pD-
ccA, grown in BHIS-Tm medium with 0, 0.01, 0.1, or 1 g/ml
nisin, was measured. The flgB transcript was included as a control.
As expected, the level of the flgB transcript decreased with increas-
ing nisin concentrations (Fig. 1B). The flgB transcript level was
significantly reduced in C. difficile with pDccA grown in 0.01
g/ml nisin, which corresponds to 2-fold-increased c-di-GMP
levels (35), compared to the uninduced vector control (Fig. 1B).
Similarly, transcript levels for tcdA were significantly reduced by
50% in C. difficile with pDccA grown in medium with 0.01 g/ml
nisin. The tcdA transcript level further decreased in a dose-depen-
dent manner.
The expression of toxin genes by C. difficile is typically studied
in the context of TY medium rather than BHIS medium, because
the tcdA toxin gene expression level is considerably higher in TY
medium (83). This is at least partly due to inhibition of toxin gene
expression by glucose (21, 83), which is present at higher levels in
BHIS than in TY medium. Therefore, we also examined the effect
of c-di-GMP on toxin gene expression in C. difficile with pDccA or
the vector during growth in TY medium. In TY medium, growth
in the presence of nisin to early stationary phase resulted in an
8-fold induction of dccA expression compared to the vector
control (see Fig. S3 in the supplemental material). This resulted in
corresponding 82%, 71%, and 93% decreases in the levels of the
flgB, sigD, and flgM transcripts, respectively (see Fig. S3 in the
supplemental material), indicating that increasing the intracellu-
lar c-di-GMP concentration represses at least some flagellar genes
in C. difficile grown in TY medium as in BHIS medium. Also
consistent with the regulation by c-di-GMP that we observed in
BHIS broth, induction of dccA during growth in TY medium de-
creased the abundance of the tcdA and tcdB transcripts by 99% and
94%, respectively (see Fig. S3 in the supplemental material). We
conclude based on these data that c-di-GMP represses several fla-
gellar genes and the tcdA and tcdB toxin genes during growth in TY
and BHIS media. Because phenotypes are readily observable in
BHIS medium as in TY medium, all subsequent experiments were
done with BHIS medium.
Next, the effects of c-di-GMP on toxin production were exam-
ined by Western blotting. TcdA toxin was assayed in cell lysates
and supernatants from C. difficile with pDccA, pDccAmut, or the
vector grown in BHIS-Tm medium with or without 1 g/ml nisin.
TcdA protein was essentially undetectable in C. difficile overex-
pressing dccA, both in the cell lysates (data not shown) and in
supernatants (Fig. 1C). Consistent with these results, supernatants
from C. difficile overexpressing dccA were less cytopathic to cul-
tured human fibroblasts than supernatants from C. difficile carry-
ing the vector (Fig. 2). Whereas culture supernatants from C. dif-
ficile with the vector caused rounding of the fibroblasts,
supernatants from C. difficile with pDccA did not. Figure 2A (top)
shows the morphologies of fibroblasts treated with the indicated
culture supernatants diluted 1:40 in tissue culture medium. As a
measure of production of functional toxin by these strains, the
titer of supernatant that caused 100% cell rounding (cytopathic
effect [CPE]) was determined (Fig. 2B). A significantly reduced
CPE on the fibroblasts was observed for C. difficile overexpressing
dccA even in exponential-phase, when the level of toxin produc-
tion is relatively low (83, 84), as well as in stationary-phase cul-
FIG 1 Expression of tcdA and tcdB in C. difficile 630 with elevated c-di-GMP
levels. (A) C. difficile strains were grown to early stationary phase (OD at 600
nm of 1.0 to 1.2) in BHIS-Tm medium with or without 1 g/ml nisin. The
levels of the tcdA and tcdB transcripts in C. difficile with the indicated plasmids
were measured by qRT-PCR. (B) Transcript abundance of tcdA and the flgB
positive control in C. difficile with the vector or pDccA, grown to early station-
ary phase in BHIS-Tm medium with the indicated concentrations of nisin, was
measured by qRT-PCR. In panels A and B, the means and standard deviations
are shown, and data were analyzed by one-way analysis of variance and Dun-
nett’s multiple-comparison test comparing values to the average for the in-
duced vector control. , P  0.05; , P  0.01; , P  0.001. (C) TCA-
precipitated supernatants from cultures of C. difficile 630 with the indicated
plasmids, grown in BHIS-Tm medium with or without 1 g/ml nisin to early
stationary phase, were probed for TcdA by Western blotting.
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tures. It should be noted that fibroblasts are particularly sensitive
to the effects of toxin B (TcdB) (85, 86). Because increasing c-di-
GMP concentrations have a more robust effect on tcdA expres-
sion, this assay may underestimate the effects of c-di-GMP on the
total cytopathicity of C. difficile culture supernatants. Taken to-
gether, these results indicate that c-di-GMP reduces expression
levels of the toxin genes, which leads to reduced toxin production
by C. difficile.
c-di-GMP impacts the expression of tcdR but not of genes
encoding other known regulators of the toxin genes. To begin to
determine the mechanism by which c-di-GMP regulates the toxin
genes, we examined the effect of elevated c-di-GMP levels on tcdR,
tcdC, codY, and sigH, which are known or suspected regulators of
tcdA and tcdB gene expression, by qRT-PCR as described above
(11, 12, 17–19, 21, 22). Of these genes, only the level of the tcdR
transcript was significantly reduced in C. difficile overexpressing
dccA (Fig. 3). While the tcdR transcript level was 13-fold lower in
C. difficile with elevated c-di-GMP concentrations than in the in-
duced vector controls, tcdC, codY, and sigH transcripts were unaf-
fected by c-di-GMP. These results indicate that c-di-GMP nega-
tively regulates the expression of the tcdR gene, which provides a
mechanism by which c-di-GMP could impact tcdA and tcdB ex-
pression. It remains possible that c-di-GMP affects the regulatory
activity of TcdC, CodY, or SigH.
The alternative sigma factor SigD positively regulates toxin
gene expression. We further examined the possibility that co-
regulation of flagellar genes and toxin genes could link toxin gene
expression to c-di-GMP levels. The sigD gene, predicted to encode
the flagellar alternative sigma factor, is among those in the flgB
operon and is negatively regulated by c-di-GMP (35). Recently, it
was reported that a mutation in sigD in C. difficile abrogates tcdR,
tcdA, and tcdB expression (34). Moreover, the sigD transcript level
was significantly reduced in several strains with mutations in the
flgB operon, each of which also showed reduced toxin gene expres-
sion. Therefore, we hypothesized that SigD positively regulates
tcdR expression and thus tcdA and tcdB expression. Repression of
sigD by c-di-GMP consequently would be expected to reduce ex-
pression levels of the toxin genes.
This hypothesis leads to the following predictions: (i) expres-
sion of sigD should positively regulate tcdR, tcdA, and tcdB expres-
sion, and (ii) ectopic expression of sigD should unlink flagellar
and toxin gene expression. To address the first prediction, because
the C. difficile sigD mutant was previously described to have de-
creased toxin gene expression levels (34), we chose to instead over-
express sigD in C. difficile to determine whether this enhances
toxin gene expression. The sigD gene was cloned into the expres-
sion vector pMC-Pcpr, allowing sigD expression to be controlled
by the addition of nisin to the growth medium (35). C. difficile
containing this expression plasmid, pSigD, or the empty vector
was grown to exponential phase in BHIS-Tm medium in the pres-
ence or absence of 1 g/ml nisin. At this phase of growth and in
this growth medium, the toxin genes are typically expressed at
very low levels (83, 84). Growth in the presence of nisin resulted in
an 30- to 50-fold increase in the sigD transcript level in C. diffi-
cile with pSigD but not the vector control, confirming that this
method allows inducible expression of sigD (Fig. 4A, left). As ev-
idence that a functional SigD was being produced, the transcript
levels for flgM, fliC, and CD0241, chosen to represent the late-
stage flagellar genes predicted to be positively regulated by SigD,
were measured. The flgM, fliC, and CD0241 transcript levels were
9.9-, 4.4-, and 2.0-fold higher, respectively, in C. difficile with
pSigD grown with nisin than in the vector control strain grown
under the same conditions (Fig. 4A, right). Thus, in all three cases,
these transcripts were significantly more abundant in C. difficile
overexpressing sigD, albeit to various degrees, indicating that SigD
FIG 2 Cytopathic effect of C. difficile 630 overexpressing dccA or sigD on fibroblasts. Supernatants from C. difficile with the indicated plasmids, grown to
exponential phase (OD at 600 nm of 0.6 to 0.8) or early stationary phase (OD at 600 nm of 1.0 to 1.2) in BHIS-Tm medium containing 1 g/ml nisin, were
applied onto monolayers of human foreskin fibroblasts. The data shown are from experiments using supernatants from early-stationary-phase cultures. (A)
Representative images of intoxicated cells and untreated controls (mock), with the dilution factors indicated. Bars  100 m. (B) CPE was evaluated after 20 h
by determining the titer at which a 100% cytopathic effect was observed. Each symbol represents the average of three measurements for each of four independent
biological samples, and the bars indicate the means and standard deviations. , P  0.05 by the Mann-Whitney test.
FIG 3 Regulation of known toxin gene regulators by c-di-GMP. The levels of
the tcdR, tcdC, codY, and sigH transcripts, as indicated at the top, in C. difficile
630 with the vector or pDccA, grown to early stationary phase (OD at 600 nm
of 1.0 to 1.2) in BHIS-Tm medium with or without 1 g/ml nisin, were
measured by qRT-PCR. The data were analyzed as described in the legend of
Fig. 1. , P  0.05 by one-way analysis of variance and Dunnett’s multiple-
comparison test comparing values to the average for the induced vector con-
trol.
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is functional in C. difficile. The transcript level of flgB was not
affected by the induction of sigD expression, indicating that there
is no autoregulation of the flgB operon by SigD.
To determine the effect of SigD on toxin gene expression, we
measured the levels of tcdR, tcdA, tcdB, and tcdC transcripts in C.
difficile with the vector or pSigD, each grown with or without 1
g/ml nisin. In C. difficile overexpressing sigD, the tcdA, tcdB, and
tcdR transcript levels were increased approximately 22-, 10-, and
11-fold, respectively, while the tcdC transcript level remained un-
changed (Fig. 4B). This expression pattern is consistent with
and complementary to the previous observation that a muta-
tion in sigD (and other mutations in the flgB operon) alters
expression of tcdR, tcdA, and tcdB but not of tcdC (34) and our
findings that c-di-GMP represses tcdA, tcdB, and tcdR but not
tcdC (Fig. 1 and 3).
The effect of SigD on expression of the toxin genes was further
demonstrated by Western blot and CPE assays. TcdA and TcdB
proteins were more abundant in cell lysates of C. difficile overex-
pressing sigD but not in the control strains (Fig. 4C). As a control,
we probed for the CodY protein and found it to be unaffected by
overexpression of sigD (Fig. 4C). Interestingly, no difference was
observed in TcdA or TcdB levels in supernatants from the same
cultures (data not shown), suggesting that sigD expression does
not substantially increase the export of the toxin proteins. Super-
natants from stationary-phase cultures of C. difficile overexpress-
ing sigD caused somewhat greater CPE on human foreskin fibro-
blasts than did supernatants from control cultures (Fig. 2A,
bottom) but not significantly so (Fig. 2B). The level of induced
CPE as a result of sigD expression was higher for supernatants
from stationary-phase cultures than for supernatants from expo-
nential-phase cultures. This result may reflect the accumulation of
SigD as a consequence of longer induction times or the need for
other growth phase-dependent regulators of toxin genes to coacti-
vate expression. Together, these results support the hypothesis
that SigD positively regulates toxin gene expression.
SigD induces toxin gene expression in the nonmotile C. dif-
ficile strain JIR8094. C. difficile JIR8094, an erythromycin-sensi-
tive derivative of strain 630, contains an undefined mutation(s)
that renders it nonmotile (see Fig. S4A in the supplemental mate-
rial). In strain JIR8094, the flgB, sigD, flgM, and CD0241 tran-
scripts were 50 to 100 times less abundant than in the 630 strain
grown under the same conditions in parallel (see Fig. S4B in the
supplemental material). We predicted that toxin gene expression
would be reduced accordingly in strain JIR8094. Indeed, the level
of the tcdA transcript was 	100 times lower in strain JIR8094 than
in the 630 parent strain (see Fig. S4B in the supplemental mate-
rial). The tcdB and tcdR transcript levels were also significantly
reduced in strain JIR8094, underscoring the tight link between
flagellar and toxin gene expression in C. difficile.
To determine whether SigD can drive toxin gene expression in
this strain that does not express flagellar genes, the pSigD expres-
sion plasmid and empty vector were introduced into C. difficile
JIR8094. The resulting JIR8094 pSigD and vector control strains
were grown in BHIS-Tm medium with or without 1 g/ml nisin,
and the levels of sigD, flgM, tcdA, tcdB, tcdR, and tcdC transcripts
in these cells were measured. The addition of nisin to C. difficile
JIR8094 with pSigD resulted in 	100-fold-increased expression
levels of sigD (Fig. 5). The flgM transcript was about 30-fold in-
duced in these samples, indicating that ectopic expression of sigD
can restore the expression of flgM in JIR8094. Upon induction of
FIG 4 Overexpression of sigD results in increased flagellar and toxin gene
expression in C. difficile 630. (A and B) C. difficile with pSigD or the vector was
grown in BHIS-Tm medium with or without 1 g/ml nisin to induce sigD
expression. Samples were collected at exponential phase (OD at 600 nm of
0.6 to 0.8), when the toxin gene expression level is relatively low. Transcript
levels of the genes indicated at the top of the panels were assessed by qRT-PCR,
as described in the text. (A) Effect of growth with nisin on sigD transcript
abundance (left) and on the abundance of select flagellar gene transcripts
(right). (B) Effect of sigD overexpression on toxin and regulator gene tran-
scripts. Shown are the means and standard deviations from at least three in-
dependent samples. In panels A and B, the data for each transcript were ana-
lyzed by one-way analysis of variance and Dunnett’s multiple-comparison test
comparing values to the average for the induced vector control. , P  0.05;
, P  0.001. (C) Detection by Western blotting of TcdA, TcdB, and CodY
in lysates of C. difficile 630 with the vector or pSigD, grown to early stationary
phase (OD at 600 nm of 1.0 to 1.2) in BHIS-Tm medium with or without 1
g/ml nisin. TcdA and TcdB migrated more slowly than the highest-molecu-
lar-mass band in the protein marker (250 kDa), as expected due to their large
size. CodY migrated at approximately 27 kDa, consistent with previous results
(19).
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sigD expression in strain JIR8094, we observed significantly in-
creased tcdA, tcdB, and tcdR transcript levels, which were 7-, 6-,
and 3-fold more abundant, respectively, in JIR8094 expressing
sigD than in the induced vector control (Fig. 5). As seen in the
wild-type strain (Fig. 4), the tcdC transcript level was unchanged.
We note that the fold changes in tcdA, tcdB, and tcdR transcript
levels are comparable in 630 and JIR8094 expressing sigD, despite
a greater induction of sigD expression in JIR8094 than in 630. This
may signify that additional factors are missing or altered in
JIR8094, preventing the full restoration of toxin gene expression
with SigD.
Evidence for direct activation of tcdR expression by SigD.
Our data show that expression of sigD results in increased expres-
sion levels of tcdR, tcdA, and tcdB, suggesting that the flagellar
sigma factor SigD activates tcdR expression, and TcdR then up-
regulates tcdA and tcdB expression. However, this does not indi-
cate whether SigD exclusively regulates the toxin genes through
induction of tcdR expression or whether SigD can also upregulate
tcdA and tcdB expression independent of TcdR. In addition, it is
unknown whether SigD activates tcdR expression directly or
whether SigD regulates another intermediate that in turn controls
tcdR. We examined the relevant promoter regions for the presence
of a SigD consensus binding sequence as an indication of direct
binding by this sigma factor. The binding site for SigD in C. diffi-
cile has not been experimentally determined. The sequence may be
similar to the FliA and SigD consensus binding sequences of E. coli
and B. subtilis, respectively, because the consensus sequences are
very similar to each other (49, 87) and because B. subtilis SigD can
functionally complement a fliA mutation in E. coli and restore
motility to the mutant (88). The consensus sequence of SigD from
E. coli is TAAA-N15-GCCGATAA, and the consensus sequence of
the orthologous SigD protein from B. subtilis is CTAAA-N16-
CCGATAT (49, 87). Approximate matches to these sequences are
present upstream of flgM (TAAA-N16-GCGATAA) and tcdR
(TATA-N15-GCCGATTA). No matches were found upstream of
tcdA, tcdB, CD0240, CD0241, or the flagellin gene fliC.
To determine whether SigD regulates the tcdR promoter di-
rectly and whether SigD can regulate the toxin gene promoters
independent of TcdR, we took multiple approaches. First, we in-
vestigated whether ectopic expression of sigD results in increased
toxin gene expression levels in a tcdR mutant as it does in wild-
type C. difficile; the loss of upregulation of tcdB and tcdB tran-
scripts upon sigD expression would indicate that SigD solely acts
on tcdR expression, with indirect effects on the toxin. We used the
Targetron method of gene inactivation to mutagenize tcdR in C.
difficile 630Erm, yielding the tcdR::ermB strain (see Fig. S5A in
the supplemental material). As expected based on previous studies
showing that TcdR is a positive regulator of tcdA and tcdB expres-
sion (11, 12), the C. difficile tcdR::ermB mutant produced substan-
tially less TcdA than did the 630Erm parent strain (see Fig. S5B in
the supplemental material). The pSigD expression plasmid and
the vector control were introduced into the C. difficile tcdR::ermB
mutant by conjugation. The two strains were then grown in
BHIS-Tm medium with or without 1 g/ml nisin to mid-expo-
nential phase; the C. difficile 630 strain carrying pSigD was in-
cluded as a control to confirm the induction of sigD in response to
nisin. We first determined the effect of sigD overexpression on
toxin protein production in the tcdR::ermB mutant by Western
blotting. Bacterial lysates from the mid-exponential-phase cul-
tures were probed for TcdA, with CodY serving as a loading con-
trol (Fig. 6A, bottom). While an increased abundance of the TcdA
protein was seen when sigD was overexpressed in the wild-type
background, there was no discernible change in TcdA levels upon
sigD expression in the tcdR::ermB background (Fig. 6A, top). Next,
the effect of sigD expression on toxin gene expression in the tcdR::
ermB mutant was assessed by qRT-PCR. In the tcdR::ermB mu-
tant, as anticipated, tcdA and tcdB transcript levels were signifi-
cantly reduced (96% and 93%, respectively) compared to those in
the wild type (see Fig. S6 in the supplemental material). As ob-
served in Fig. 4, sigD expression in the wild-type background led to
increased tcdA and tcdB transcript levels (Fig. 6B). However, in the
tcdR::ermB mutant, in which the induction of sigD expression was
comparable (4.5-fold), no significant differences in the tcdA or
tcdB transcript levels were detected (Fig. 6C). Together, these re-
sults indicate that TcdR is required to mediate activation of tcdA
and tcdB expression by SigD.
As an additional strategy, we coexpressed sigD along with a
transcriptional fusion of lacZ to our promoters of interest in B.
subtilis. The rationale for this experiment is that any C. difficile-
specific factors that could mediate SigD activation of C. difficile
toxin or flagellar promoters are likely to be absent in B. subtilis.
Thus, increased reporter activity in response to SigD production
would indicate direct SigD-mediated activation of the promoter
in question. To do this, we began with B. subtilis strain MC202, in
which the C. difficile two-component system cprR-cprK that senses
and responds to nisin has been integrated at the sacA locus (78).
Using strain MC190, which contains cprR-cprK as well as a lacZ
fusion to the Pcpr promoter, used here to drive expression in re-
sponse to nisin in C. difficile (78), we confirmed that these B.
subtilis strains are capable of responding to nisin in a dose-depen-
dent manner (data not shown). We inactivated the endogenous
sigD gene by transformation of MC202 with genomic DNA from a
previously described B. subtilis sigD mutant (50), generating strain
RT838. We then introduced two additional fusions at the amyE
locus: the Pcpr::sigD fusion, which allows nisin-inducible expres-
sion of sigD, and a lacZ fusion to the tcdA, tcdB, tcdR, or flgM
promoter. The two fusions were transformed into RT838 on a
FIG 5 Overexpression of sigD partially restores toxin gene expression in non-
motile C. difficile JIR8094. C. difficile JIR8094 with pSigD or the vector was
grown to mid-exponential phase (OD at 600 nm of 0.6 to 0.8) in BHIS-Tm
medium with or without 1 g/ml nisin. Expression of the flagellar and toxin-
related genes indicated at the top was assessed by qRT-PCR, as described in the
text. Shown are the means and standard deviations from at least three inde-
pendent samples. The data for each transcript were analyzed by one-way anal-
ysis of variance and Dunnett’s multiple-comparison test comparing values to
the average for the induced vector control. , P  0.01; , P  0.001.
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single plasmid in which the fusions are adjacent and divergently
encoded. Thus, with the final strains, we used nisin to induce sigD
expression and measured the effect of the resulting C. difficile SigD
production on tcdA, tcdB, tcdR, and flgM promoter activity using
-galactosidase reporter assays.
The B. subtilis reporter strains were grown for 6 h at 37°C in LB
medium containing 0, 0.5, 1.0, or 2.0 g/ml nisin to induce sigD
expression. The baseline -galactosidase activity (i.e., activity de-
tected in uninduced cultures) varied depending on the promoter,
likely indicating differences in promoter strength in the B. subtilis
host. The baseline activity for the PtcdR::lacZ reporter grown in the
absence of nisin was particularly low. The PflgM::lacZ reporter
strain, which we included as a positive control given our evidence
that SigD positively regulates flgM expression, showed approxi-
mately 4- to 8-fold-higher -galactosidase activity when grown in
the presence of nisin (Fig. 7, left). Activation of PflgM::lacZ activity
was dose dependent to a degree, with 1 g/ml nisin being suffi-
cient for maximal expression. -Galactosidase activity remained
relatively unchanged in the PtcdA::lacZ and PtcdB::lacZ reporter
strains regardless of the addition of nisin, with the exception of a
small increase in activity in the PtcdB::lacZ reporter strain at the
highest nisin concentration (Fig. 7, right). In contrast, the PtcdR::
lacZ reporter showed a marked dose-dependent increase in -ga-
lactosidase activity. In the presence of 2 g/ml nisin, a 70-fold
increase in activity was observed compared to that of the unin-
duced control. These data indicate that C. difficile SigD activates
the flgM and tcdR promoters but not the tcdA or tcdB promoters.
Moreover, because these experiments were performed with B.
subtilis, and thus in the absence of other C. difficile-specific factors,
the effect of SigD on flgM and tcdR is likely through direct binding
to these promoters.
DISCUSSION
The two glucosylating toxins produced by C. difficile, TcdA and
TcdB, play a central role in the development of disease symptoms
in CDI (9, 10). There is great interest in understanding how these
toxins are regulated, as this knowledge may lead to the identifica-
tion of ways to inhibit toxin production to thereby reduce CDI.
In this work, we show that the second messenger c-di-GMP re-
presses the expression of the C. difficile toxin genes tcdA and tcdB
as well as the expression of the tcdR gene. We also provide evi-
dence that c-di-GMP regulation of tcdR, and thereby tcdA and
tcdB, likely occurs through the control of expression of the alter-
native flagellar sigma factor gene sigD. Furthermore, our data sug-
gest that SigD activates tcdR expression by interacting directly
with the tcdR promoter and that SigD cannot activate tcdA and
tcdB toxin gene expression independent of TcdR.
The ectopic expression of sigD in C. difficile was shown to in-
crease the level of several flagellar gene transcripts, providing evi-
dence that SigD is functional in C. difficile. Interestingly, sigD
overexpression led to a 10-fold increase in the level of the flgM
transcript, indicating that SigD regulates the expression of its own
antagonist. This might be expected to neutralize the effects of sigD
overexpression, but this was not observed. One possibility is that
C. difficile encodes a nonfunctional FlgM; however, this has not
been determined experimentally. Alternatively, the high level of
SigD achieved through overexpression could exceed the amount
FIG 6 TcdR is required for SigD-mediated induction of toxin gene expression. C. difficile 630 with pSigD and the C. difficile 630Erm tcdR::ermB strain with the
vector or with pSigD were grown to mid-exponential phase (OD at 600 nm of 0.6 to 0.8) in BHIS-Tm medium with or without 1 g/ml nisin. (A) The ability
of SigD to induce toxin production in the absence of TcdR was assessed by probing for TcdA in bacterial lysates by Western blotting. The CodY protein was used
as a loading control. Shown is a representative image from two independent experiments. WT, wild type. (B and C) The effect of sigD overexpression on toxin
gene expression in the absence of TcdR was determined by qRT-PCR. (B) The sigD, tcdA, and tcdB transcripts in C. difficile 630 with pSigD were measured to
confirm sigD induction and consequent effects on tcdA and tcdB transcript levels in response to growth with nisin. Shown are the means and standard deviations
(n  5). , P  0.05; , P  0.01 (determined by the Mann-Whitney test comparing values obtained with and those obtained without nisin for each transcript).
(C) In parallel, the transcript levels of sigD, tcdA, and tcdB were determined for the C. difficile 630Erm tcdR::ermB strain with the vector or pSigD. Shown are the
means and standard deviations (n  5). , P  0.001 by one-way analysis of variance and Dunnett’s multiple-comparison test comparing values to the average
for the induced vector control.
FIG 7 Effect of C. difficile sigD expression on flgM, tcdR, tcdA, and tcdB pro-
moter activities. The B. subtilis reporter strains were grown in LB broth sup-
plemented with nisin at 0, 0.5, 1.0, and 2.0 g/ml to induce expression of C.
difficile sigD. -Galactosidase activity was measured to determine the activity
of the reporter fusions indicated on the x axis. The assay was performed with
three independent samples of each strain at each nisin concentration. Means
and standard deviations are shown. The data were analyzed by an unpaired t
test comparing induced cultures to the uninduced cultures for each strain. ,
P  0.05; , P  0.01; , P  0.001.
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of FlgM in the cell. Thus, FlgM would effectively titrate a portion
of available SigD, but sufficient SigD would remain in excess to
activate other target promoters.
The data here reiterate that toxin gene expression is tied to the
expression of flagellar genes. A link between flagellar and toxin
gene expression was recently demonstrated (33, 34). The mecha-
nism connecting the two was not addressed, although SigD was
implicated in work by Aubry et al. (34). Specifically, it was shown
that a C. difficile sigD mutant expresses the tcdR, tcdA, and tcdB
toxin genes at dramatically lower levels, which is consistent with
our finding that overexpression of sigD in C. difficile leads to in-
creased tcdR, tcdA, and tcdB transcript levels. A likely scenario is
that SigD activates the expression of tcdR, which in turn activates
the expression of the toxin genes. This is supported by our
finding that sigD overexpression in a C. difficile tcdR mutant does
not lead to increased toxin gene expression or increased produc-
tion of the TcdA protein. Furthermore, we provide evidence that
SigD directly activates tcdR expression using a reporter system in a
heterologous bacterial host, B. subtilis, in which C. difficile-specific
regulatory factors are absent. The induction of sigD in this system
led to the activation of the flgM and tcdR promoters but not the
tcdA or tcdB promoters. Together, these data support the conclu-
sion that upregulation of tcdA and tcdB in C. difficile by SigD
occurs solely through TcdR. We attempted electrophoretic mobil-
ity shift assays using purified His6-tagged SigD and promoters of
interest to determine whether SigD interacts directly with the tcdR
promoter. However, we were unable to purify SigD-His6 in a suf-
ficient amount or with sufficient purity to complete these experi-
ments, and we could not detect a shift of the flgM promoter, which
served as the positive control. Additional studies will be necessary
to determine if and how SigD interacts with the tcdR promoter.
The connection between flagellar and toxin gene expression
observed previously (34) is supported by the differences seen be-
tween C. difficile strain 630 and the nonmotile derivative JIR8094.
Our data show that strain JIR8094 not only expresses flagellar
genes at levels that are orders of magnitude lower than strain 630,
JIR8094 also expresses toxin genes at significantly lower levels.
This observation may help explain conflicting results regarding
the relative importance of TcdA and TcdB toxins to C. difficile
virulence. Kuehne et al. demonstrated previously that both toxins
play important roles in virulence in hamsters by using the C. dif-
ficile 630Erm strain and tcdA and tcdB mutant derivatives (9). An
earlier study showed that hamsters infected with C. difficile tcdB
mutants, but not tcdA mutants, survived longer than hamsters
infected with the parental strain, indicating that TcdB is the major
virulence factor of C. difficile (10). However, the latter study used
JIR8094 as the parental strain. The differences in outcomes of the
studies by Lyras et al. and Kuehne et al. have been attributed to
genetic differences between strains 630Erm and JIR8094, both of
which were derived from strain 630 by serial passaging (89–91).
Indeed, differences in toxin production between the two strains
were reported previously, with strain 630Erm producing 3-fold
more toxin than the JIR8094 derivative (91). These results are
consistent with our findings that the tcdA transcript is 100-fold
more abundant in strain 630 than in strain JIR8094. Thus, work-
ing with strain JIR8094 may have led to an underestimation of the
importance of TcdA to virulence, as the relative difference in tcdA
expression levels between strain JIR8094 and its tcdA mutant de-
rivative would be smaller than that in the 630 background. Fur-
thermore, because it is less toxigenic but clearly virulent, strain
JIR8094 may be a good genetic background for studying other
putative virulence factors in the hamster model, which is ex-
tremely sensitive to C. difficile toxins. Finally, it is interesting to
speculate that so-called hypervirulent, epidemic strains that pro-
duce higher levels of toxin may do so because of increased flagellar
gene, and in particular sigD, expression levels. This is supported by
the observation that epidemic strain R20291 is more motile than
strain 630 (92), although this was not reproduced by using a
slightly different motility assay (35).
A precedent for the regulation of genes unrelated to motility
and chemotaxis by SigD homologues exists for several bacterial
species (93–97). For example, in the diarrheal pathogen Vibrio
cholerae, the SigD orthologue FliA similarly augments the produc-
tion of cholera toxin (98). This occurs as result of FliA repression
of the quorum-sensing regulator HapR (a negative regulator of
cholera toxin genes), leading to derepression of cholera toxin
genes (98). It was recently demonstrated that in C. difficile, the Agr
quorum-sensing system broadly impacts flagellar gene expression
as well as the expression of tcdA (99). Regulation may occur
through modulation of c-di-GMP, as the agr mutant also showed
reduced expression levels of multiple genes encoding c-di-GMP
hydrolytic enzymes. Quorum sensing and c-di-GMP signaling
may thus work together to modulate flagellar and toxin gene ex-
pression in C. difficile. Finally, c-di-GMP and SigD may have
broader effects on gene expression beyond controlling flagellar
and toxin genes in C. difficile, so characterizing the c-di-GMP and
SigD regulons is also of interest.
During growth in rich medium in vitro, flagellar and toxin
genes appear to be expressed at distinct growth phases. C. difficile
expresses flagellar genes at higher levels during exponential
growth than during early stationary phase (22). Conversely, the
production of the TcdA and TcdB toxins is negligible during ex-
ponential phase but is upregulated during stationary phase (83,
84, 100). Growth phase-dependent control of toxin production
occurs at least in part through the activities of CodY and CcpA,
which respond to nutrient depletion in the growth medium and
derepress toxin genes during stationary phase and/or nutrient
limitation (18–21). The in vitro data presented suggest that the
effect of SigD expression on toxin gene expression is counteracted
by the activities of CodY and/or CcpA during exponential growth
but is unmasked during stationary phase as CodY and CcpA be-
come inactive. However, it is unlikely that studies performed by
using bacteria grown in rich medium, either TY (peptide-rich,
low-glucose) or BHIS (peptide-rich, higher-glucose) medium,
fully and accurately reflect the dynamics of flagellum and toxin
regulation during infection, because glucose, amino acids, and
peptides are scarce in the large bowel. During infection, regulation
of toxin genes is likely more complex, involving an interplay be-
tween c-di-GMP, SigD, and other known or suspected regulators
to precisely modulate toxin gene expression so that the bacteria
produce toxin at the appropriate phase of infection. Nonetheless,
SigD is clearly an important activator of toxin genes during infec-
tion, as evidenced by the dramatic attenuation of virulence in C.
difficile flagellar mutants that produce less toxin (34) and the en-
hanced virulence of fliC and fliD mutants that produce more toxin
(33). Future studies investigating the host signals impacting the
level of intracellular c-di-GMP and the activities of other toxin
gene regulators may elucidate the in vivo pathways controlling C.
difficile virulence factor production.
The current study highlights the importance of c-di-GMP as a
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regulator of C. difficile motility and toxin production. The work-
ing model of how c-di-GMP impacts toxin production, based on
our and others’ data, begins with c-di-GMP binding to the Cd1
riboswitch in the predicted 5= untranslated region (UTR) of the
flgB operon, which likely includes sigD (see Fig. S1 in the supple-
mental material), to inhibit its expression (45, 46). As a result,
SigD will fail to activate expression of the late-stage flagellar oper-
ons, as we observed for C. difficile with high c-di-GMP levels.
Because SigD also activates the expression of tcdR, c-di-GMP also
represses toxin production. This model suggests that increases in
c-di-GMP levels during the course of a C. difficile infection would
cause reduced TcdA and TcdB production, possibly mitigating the
virulence of the bacterium. Thus, components of the c-di-GMP
signaling pathway, including the Cd1 riboswitch, are promising
candidate targets for interfering with the ability of C. difficile to
cause disease. Furthermore, determining the host-derived cues
that impact bacterial intracellular c-di-GMP levels will inform us
of the signals affecting virulence factor production of C. difficile.
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